Tag: Zhu Min
Out-licensing is in
China's out-licensing boom: legal experts share tips for seamless pharma deals
Firms act on Hengrui-GSK USD12.5bn drug development deal
Jiangsu Hengrui and GSK reached a USD12.5bn deal, with Cooley, Davis Polk and Han Kun advising
Han Kun advises 3SBio in landmark Pfizer licensing deal
3SBio inks major licensing deal with Pfizer for cancer drug SSGJ-707













